Search

Few direct matches — filled in with the latest updates.

Tag: #china-healthcare1 results

Pharma Reps Urge AI Boost

Pharma Reps Urge AI Boost

At China's two sessions, pharma leaders like Sun Piaoyang highlight innovative drug hospital access issues and advocate AI integration in R&D, primary care, TCM, and obesity management. Suggestions include subsidies for AI doctor assistants and AI-driven breakthroughs in key technologies. This aims to enhance innovation conversion and grassroots healthcare.

Anduril Raises $5B on AI Defense Infrastructure

Anduril Raises $5B on AI Defense Infrastructure

Anduril Industries reportedly completed a $5 billion Series H financing at a $61 billion valuation, reinforcing its position as a major defense-technology company. The article highlights its Lattice AI platform, flexible Arsenal-1 manufacturing system, and Palmer Luckey’s view that China’s engineering and manufacturing efficiency could reshape future military competition.

📰

When AI Diagnoses Clash With Doctors

Patients are increasingly bringing answers from Doubao and other AI assistants into hospitals, sometimes challenging doctors' diagnoses and requesting unnecessary tests. The article documents how AI hallucinations, incomplete symptom interpretation, and misplaced patient trust are increasing consultation time and worsening doctor-patient friction.

Kling AI Becomes Kuaishou’s Growth Engine

Kling AI Becomes Kuaishou’s Growth Engine

Kling AI generated more than RMB 850 million in Q2 revenue, up 240% year over year, making it the standout growth driver in Kuaishou’s otherwise slowing business. Kuaishou is prioritizing AI investment, spinning Kling AI out for independent financing at an implied valuation of US$18 billion despite near-term profit pressure.